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Chronic kidney disease in Costa Rica
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Chronic kidney disease in Costa Rica. Costa Rica is one of the
Central American countries, located between Nicaragua to the
north and Panama to the south. Like other Latin American
countries, Costa Rica deals with social and economic problems
associated with poverty, except for one significant difference—
Costa Rica has not had an army since 1948, and so the peo-
ple and government can spend more money on education and
health. For this reason, Costa Rica is very different from other
Latin American countries. We do not need weapons, and we
have had a democratic tradition for 100 years.
Despite our economic and social limitations, Costa Ricans
have universal access to a health system that covers 98% of the
inhabitants. Renal replacement therapy (RRT) is accessible to
all who need it. In the last 5 years, Costa Rica has doubled the
number of patients on hemodialysis, and has the highest num-
ber of kidney transplants per million population (pmp) in Latin
America, with 20.63 transplants pmp in 2000, 27.25 transplants
pmp in 2001, and 24.81 transplants pmp in 2002. However, the
prevalence of all forms of RRT in Costa Rica is currently 193
pmp. This suggests that end-stage renal disease is underdiag-
nosed in Costa Rica as it is in many other Latin American coun-
tries. Greater research efforts are needed to determine the true
extent of renal disease in Costa Rica and to optimize the use
of health-sector resources to provide a better and more robust
program of RRT for patients with end-stage renal disease.
Resumen
Costa Rica es un paı´s centroamericano que limita al norte
con Nicaragua y al sur con Panama´. Como el resto de paı´ses
latinoamericanos, enfrenta los problemas sociales y econo´micos
asociados a la pobreza, con una gran diferencia. Costa Rica no
tiene eje´rcito, lo que le permite a sus habitantes y gobierno el
destinar ma´s recursos a la educacio´n y la salud.
A pesar de sus limitaciones econo´micas, los costarricenses
gozan de un acceso universal al sistema de salud, el cual cubre un
98% de su poblacio´n. Las terapias de reemplazo de la funcio´n
renal son accesibles a todo el que lo necesita. En los u´ltimos
cinco an˜os el nu´mero de pacientes en hemodia´lisis se ha du-
plicado. La tasa de trasplante renales por millo´n de habitantes
(pmh) es la ma´s alta en Ame´rica Latina, con 20.63 trasplantes
pmh realizados en el 2000, 27.25 pmh en el 2001 y 24.81 en el
2002. Sin embargo, la prevalencia de pacientes en terapia de
reemplazo es de solo 193 pmh, sugiriendo que la insuficiencia
renal cro´nica se encuentra sub-diagnosticada, tal como sucede
en otros paı´ses latinoamericanos. Es necesario por lo tanto, el
realizar un mayor esfuerzo para determinar la magnitud real
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de esta enfermedad y optimizar los recursos del sector salud,
para proporcionar un mayor y mejor programa de terapia de
reemplazo en el paciente con falla renal.
Costa Rica is one of the smallest countries in Latin
America, covering an area of 51,100 square kilometers,
with a population of 4,008,265. Ethnically, the population
of Costa Rica is predominantly white, with blacks and mu-
lattos constituting the second largest ethnic group. Costa
Rica has a very large middle class comprising 50% of the
urban population and 50% of the rural population [1].
The index of human development for Costa Rica, cal-
culated on the basis of longevity, education, and purchas-
ing power, is 0.821—one of the best in the Americas, be-
hind only that of Canada and Chile—together with a gross
national product of US $4,100 per capita [2]. Costa Rica is
one of the most socioeconomically homogeneous coun-
tries in Latin America and has one of the best public
health systems in the region. Public nephrology services
have been available since 1968, and the first kidney trans-
plant was performed in 1969. All nephrology services be-
long to the social security system, and all citizens have
free access to medical attention.
COMMON RENAL DISEASES
The data presented here were derived from informa-
tion published by the Biostatistics Department of the
Caja Costarricense del Seguro Social [3]. The public
health system of Costa Rica covers 98% of the popu-
lation, who are attended to in 9 national hospitals, 20 re-
gional hospitals, 178 clinics, and 822 Basic Equipment for
Integrated Health Assistance units—one for every 4000
people. A single Basic Equipment for Integrated Health
Assistance unit is formed by a physician, nurse, and health
technician.
The total number of “outpatient consultations with
kidney disease” in the social security system was 8456
patients in 1997 and 31,174 patients in 2002.
The number of “discharged patients with kidney dis-
ease” diagnosed in the social security system for the year
2002 were as follows: chronic renal failure (406 patients),
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Table 1. Pathology diagnoses [2000–2002], 200 kidney biopsies,
Mexico Hospital (primary disease)
Diagnosis Number Percentage
Crescent glomerulonephritis 14 7.0
IgA nephropathy 8 4.0
Minimal change nephropathy 7 3.5
Thin basement membrane nephropathy 1 0.5
Amyloidosis 1 0.5
Interstitial nephritis 10 5.0
Membranoproliferative glomerulonephritis 10 5.0
Membranous nephropathy 16 8.0
Nephrosclerosis 4 2.0
Mesangial proliferative glomeruleronephritis 14 7.0
Focal and segmental glomeruloesclerosis 19 9.5
Uncertain 14 7.0
Abbreviation: IgA, immunoglobulin A.
Table 2. Pathology diagnoses [2000–2002], 200 kidney biopsies,
Mexico Hospital (secondary disease)
Diagnosis Number Percentage
Diabetic nephropathy 1 0.5
Lupus glomerulonephritis 53 26.5
Transplant glomerulopathy 5 2.5
Acute rejection 12 6.0
Chronic rejection 11 5.5
diabetic nephropathy (377 patients), and glomerular dis-
eases (447 patients).
I looked at the causes of common primary and sec-
ondary renal disease in my hospital (Mexico Hospital,
San Jose, Costa Rica), which attends to the renal prob-
lems of about two million Costa Rican citizens per year
and nearly 250,000 people from Nicaragua (Tables 1
and 2).
END-STAGE RENAL DISEASE
Costa Rica does not have a complete nationwide reg-
istry of renal disease. Nonetheless, data from the 4 prin-
cipal dialysis centers of Costa Rica, which had 226 pa-
tients in 2000, shows that chronic glomerulonephritis was
the leading cause (30% of cases) of end-stage renal dis-
ease (ESRD), followed by diabetic nephropathy (20% of
cases) and hypertensive nephrosclerosis (15% of cases).
Other etiologies were obstructive nephropathy (3% of
cases), interstitial nephritis (10% of cases), cystic renal
disease (10% of cases), and lupus glomerulonephritis
(2% of cases). This pattern is similar to that found in
other Latin American countries [4].
Costa Rica has a different pattern of chronic renal
disease in the north part of the country, in Guanacaste,
where, in the last five years there has been an epidemic
of chronic renal failure. The demographic features of pa-
tients are very interesting. All are young men, between
the ages of 20 and 40 years, with a clinical and pathologic
picture of chronic interstitial nephritis. The most inter-
esting feature of these patients is epidemiologic—all of
them are long-term sugar-cane workers. A specific study
of their work environment is needed to determine what
in their daily activities puts them at increased risk for
chronic renal failure.
RENAL REPLACEMENT THERAPY IN COSTA
RICA
Dialysis
The overall renal replacement therapy (RRT) rate for
Costa Rica was 193 per million population (pmp) in 2002.
It is lower than the overall RRT rate for Latin America,
which is 300 pmp [4], and that of the United States, which
is 1100 pmp [5]. This suggests that chronic renal disease
is underdiagnosed and probably undertreated in Costa
Rica.
Access to medical services in Costa Rica is universal;
we practice sophisticated medicine, medication is freely
distributed to all renal patients, and all citizens have a
constitutional right to RRT.
Patients in the public medical service have had access
to nephrology care since 1968, and in 1972 an official
hemodialysis program was implemented for patients with
ESRD. Hemodialysis has been a safe procedure in Costa
Rica, with an annual mortality rate of 25%. All cases are
covered by social security (approximately US $23,000 per
year), which provides 100% of the drug treatment admin-
istered to these patients (e.g., erythropoietin, calcitriol,
and antihypertensive drugs). New regulations require wa-
ter treatment via reverse osmosis, prohibit reuse, and re-
quire more biocompatible dialyzers such as polysulphone
and cellulose acetate [6].
On the other hand, RRT has several limitations. We
have only 4 hemodialysis centers in the capital city, San
Jose. All patients must travel many hours to these cen-
ters. In addition, the number of hemodialysis machines is
relatively small, with 40 machines to attend to about 110
patients.
We also have a continuous ambulatory peritoneal dial-
ysis program with about 35 patients, and regular patients
in intermittent peritoneal dialysis.
The number of nephrologists per million people (cor-
responding to 1 nephrologist per 250,000 inhabitants) is
significantly lower than that of other Latin American
countries [6]. The Costa Rican Society of Nephrology is
working toward the promotion and formation of more
new nephrologists, at least 2 per year.
Transplantation
The predominant RRT modality in Costa Rica is kid-
ney transplantation. Costa Rica has one of the best situ-
ations of renal transplantation in Latin America [4]. The
first kidney transplant was performed in 1969, and the
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total number of kidney transplants as of December 2002,
was 1154 (105 in children).
We have 4 kidney transplant centers. The initial cost
of each kidney transplantation is US $6000. Use of living
donors predominates in Costa Rica (70% of the cases).
In 2002, we performed transplantation in 56% of our
patients on dialysis. Immunosuppressive treatments in-
clude steroids, cyclosporine, azathioprine, mycopheno-
late mofetil, and in some cases anti-CD 25 antibodies.
Cost of immunosuppressive treatment for the first year
with mycophenolate mofetil is US $7538 and with aza-
thioprine, US $3032. Recently, some transplant centers
introduced tacrolimus into the immunosuppressive pro-
tocol.
The number of kidney transplants in Costa Rica was
20.63 pmp in 2000, 27.25 pmp in 2001, and 24.81 pmp
in 2002—one of the best statistics in Latin America. But
more efforts are needed to improve kidney donation, es-
pecially cadaveric renal donation.
CONCLUSION
Costa Rica has one of the best public health care sys-
tems in the world, but greater efforts are needed in the
field of renal disease to improve RRT. Although trans-
plantation is the predominant RRT modality, access to
RRT is limited by socioeconomic factors. ESRD is still
underdiagnosed in Costa Rica, and some of patients with
ESRD die of terminal renal disease. We must also make
a greater effort to reduce the prevalence of chronic renal
disease. Finally, Costa Rica needs to develop new, innova-
tive health policies for the promotion and improvement
of various RRTs. In the short term, health sector and
government authorities need to establish preventive pro-
grams in the field of renal disease.
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